Daily briefing: The return of the snail - the month's best science images
Cancer blood tests show promise but lack regulatory approval and randomized trials, with concerns about false positives outweighing benefits for widespread adoption.
I'm on the Meta Oversight Board. We need AI protections now | Suzanne Nossel
AI development lacks adequate government regulation despite known dangers, creating safety risks while companies prioritize profit and competitive advantage over public protection.
5 ways to be great AI agent manager, according to business leaders
Antony Hausdoerfer emphasized that successful AI managers must ensure AI agents deliver trusted value and safe operations, focusing on applications that yield meaningful outcomes.